Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells
| Autor: | Laura Cella, Roberto Pacelli, Silvana Libertini, Giuseppe Portella, Gunnel Halldén, Massimiliano Volpe, David A. Gillespie, Ginevra Botta, Antonella Abagnale, Carmela Passaro |
|---|---|
| Přispěvatelé: | C., Passaro, A., Abagnale, S., Libertini, M., Volpe, G., Botta, L., Cella, Pacelli, Roberto, G., Hallden, D., Gillespie, Portella, Giuseppe |
| Rok vydání: | 2013 |
| Předmět: |
Oncolytic adenovirus
Cancer Research Programmed cell death DNA damage Endocrinology Diabetes and Metabolism Mice Nude Biology Thyroid Carcinoma Anaplastic Virus Replication Adenoviridae Mice Endocrinology Viral life cycle Cell Line Tumor Radiation Ionizing Animals Humans Thyroid Neoplasms Oncolytic Virotherapy Cell Death Kinase Combined Modality Therapy Tumor Burden Oncolytic virus Oncolytic Viruses HEK293 Cells Oncology MRN complex Viral replication Immunology Cancer research DNA Damage |
| Zdroj: | Endocrine-related cancer 20 (2013): 633–647. doi:10.1530/ERC-13-0001 info:cnr-pdr/source/autori:Passaro C, Abagnale A, Libertini S,Volpe M,Botta G,CELLA L.,Pacelli R,Halldèn G,Gillespie D and Portella G./titolo:Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells./doi:10.1530%2FERC-13-0001/rivista:Endocrine-related cancer/anno:2013/pagina_da:633/pagina_a:647/intervallo_pagine:633–647/volume:20 |
| ISSN: | 1479-6821 1351-0088 |
| Popis: | dl922–947 is an oncolytic adenovirus potentially suitable for the treatment of aggressive localized tumors, such as anaplastic thyroid carcinoma (ATC). In this study, we have analyzed the effects of dl922–947 in combination with ionizing radiations, testing different schedules of administration and observing synergistic effects only when ATC cells were irradiated 24 h prior to viral infection. Cells undergoing combined treatment exhibited a marked increase in cell death and viral replication, suggesting that irradiation blocks cells in a more permissive state for viral life cycle. We also show that dl922–947 triggers a DNA damage response, characterized by mobilization of the MRN complex (composed by Mre11-Rad50-Nbs1), accumulation of γH2AX, and activation of the checkpoint kinases ataxia telangiectasia mutated (ATM) and Chk1. Based on these observations, we speculate that the DNA damage response acts as a cellular protective mechanism to hinder viral infection and replication. To confirm this hypothesis, we demonstrate that the ATM inhibitor KU55933 increased the oncolytic activity of dl922–947 and its replication. Finally, we validate the potential therapeutic use of this approach by showing in vivo that the combined treatment slows tumor xenograft growth more potently than either irradiation or infection alone. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|